Co-induction of cyclooxyenase-2 and early growth response gene (<it>Egr-1</it>) in spinal cord in a clinical model of persistent inflammation and hyperalgesia

<p>Abstract</p> <p>Background</p> <p>This study characterised the effects of persistent peripheral inflammation of the foot on pain and spinal cord expression of cyclooxygenase-1 and -2 (COX-1 and COX-2) and early growth response gene 1 (<it>Egr-1</it>), kno...

Full description

Saved in:
Bibliographic Details
Main Authors: Dolan Sharron (Author), Hastie Peter (Author), Crossan Claire (Author), Nolan Andrea M (Author)
Format: Book
Published: SAGE Publishing, 2011-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_5e7ec4d341d24ff5a9cf514c61b579f4
042 |a dc 
100 1 0 |a Dolan Sharron  |e author 
700 1 0 |a Hastie Peter  |e author 
700 1 0 |a Crossan Claire  |e author 
700 1 0 |a Nolan Andrea M  |e author 
245 0 0 |a Co-induction of cyclooxyenase-2 and early growth response gene (<it>Egr-1</it>) in spinal cord in a clinical model of persistent inflammation and hyperalgesia 
260 |b SAGE Publishing,   |c 2011-11-01T00:00:00Z. 
500 |a 10.1186/1744-8069-7-91 
500 |a 1744-8069 
520 |a <p>Abstract</p> <p>Background</p> <p>This study characterised the effects of persistent peripheral inflammation of the foot on pain and spinal cord expression of cyclooxygenase-1 and -2 (COX-1 and COX-2) and early growth response gene 1 (<it>Egr-1</it>), known markers of neuronal plasticity, in a clinical model of naturally-occurring inflammatory disease and hyperalgesia in sheep ('footrot'), before and after routine treatment (parenteral treatment with antibiotics and antiseptic footbathing). The temporal pattern of expression of COX-1, COX-2 and <it>Egr-1 </it>mRNA and protein were analysed using real-time PCR and Western blotting.</p> <p>Results</p> <p>Animals affected with persistent peripheral inflammation displayed significant hyperalgesia and lameness (a proxy indicator of spontaneous pain) restricted to the inflamed limb. Hyperalgesia and lameness were significantly attenuated 1 day after treatment, and resolved further by day 7 and day 3, respectively. COX-2 but not COX-1, protein expression was up-regulated in spinal cord from lame animals on day 0, before treatment. Following treatment and attenuation of pain behaviours, levels of COX-2 returned to control levels. Significant induction of <it>Egr-1 </it>mRNA and protein were observed in spinal cord from lame animals. Three days after treatment, levels of <it>Egr-1 </it>mRNA returned to control levels, however, <it>Egr-1 </it>protein remained elevated.</p> <p>Conclusion</p> <p>Elevated levels of spinal COX-2 and <it>Egr-1 </it>protein correlate with the presence of pain and hyperalgesia, and may underlie persistent pain, although a direct causal link has still to be established. Understanding the temporal pattern of expression of key mediators in clinical pain states may lead to better strategies to manage pain.</p> 
546 |a EN 
690 |a Inflammation 
690 |a pain 
690 |a hyperalgesia 
690 |a Egr-1 
690 |a cyclooxygenase-2 
690 |a spinal cord 
690 |a Pathology 
690 |a RB1-214 
655 7 |a article  |2 local 
786 0 |n Molecular Pain, Vol 7, Iss 1, p 91 (2011) 
787 0 |n http://www.molecularpain.com/content/7/1/91 
787 0 |n https://doaj.org/toc/1744-8069 
856 4 1 |u https://doaj.org/article/5e7ec4d341d24ff5a9cf514c61b579f4  |z Connect to this object online.